Showing 6831-6840 of 20413 results for "".
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/rethinking-frontline-care-in-her2-metastatic-breast-cancer/39714/Patients with HER2- metastatic breast cancer may not always reach later lines of therapy, which means early treatment decisions and biomarker testing are increasingly important to optimizing outcomes. Joining Dr. Alexandria May to discuss the evolving treatment landscape and the role of precision meHow Symptoms Shape Caregiver Burden in ATTR-CM
https://reachmd.com/programs/Audioabstracts/caregiver-burden-attr-cm/49075/New findings from a post hoc analysis of the Burden of Disease survey highlight how symptom severity and loss of independence in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to increased caregiver burden, fatigue, anxiety, and depression. In this AudioAbstract, Ryan QuigleExploring Deeper Silencing in Transthyretin Amyloidosis
https://reachmd.com/programs/Audioabstracts/deeper-ttr-silencing-attr/49074/New real-world data are reshaping the conversation around transthyretin suppression in transthyretin amyloidosis. In this AudioAbstract, Ryan Quigley explains how a crossover analysis revealed substantially deeper serum transthyretin suppression with vutrisiran than patisiran, raising important quesRethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
https://reachmd.com/programs/dermconsult/rethinking-quality-of-life-tools-for-psoriasis-patients-with-skin-of-color/39691/Psoriasis can have a disproportionate quality-of-life impact on patients with skin of color, but commonly used tools like the Dermatology Life Quality Index (DLQI) may not fully capture the social, emotional, and cultural burden unique to these patients. Join Dr. Megan Hauptman as she explores the lPersonalizing Treatment in Moderate-to-Severe Psoriasis
https://reachmd.com/programs/dermconsult/personalize-moderate-severe-psoriasis-care/39689/With an expanding range of biologic and oral therapies available for moderate-to-severe plaque psoriasis, treatment selection is becoming increasingly nuanced. That's why Dr. James Song joins us to share a practical, systematic approach to choosing therapy. Tune in to learn about key considerations,Recognizing and Managing Swelling in ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/manage-swelling-attr-cm/49042/Swelling and fluid retention in transthyretin amyloid cardiomyopathy (ATTR-CM) can signal worsening congestion, even before overt edema develops. In this discussion with Dr. Steve Jackson, Dr. Kevin Shah shares practical guidance on identifying subtle early symptoms, monitoring patients, and tailoriUnderstanding Real-World Testing Patterns in ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/real-world-testing-attr-cm/49043/As recognition of transthyretin amyloid cardiomyopathy (ATTR-CM) continues to increase, new Medicare claims data highlights significant gaps between guideline-recommended diagnostic pathways and real-world testing. Learn more as Dr. Steve Jackson and Dr. Ronald Witteles review the findings andBuilding on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
https://reachmd.com/programs/project-oncology/progress-alk-positive-nsclc/49144/As outcomes improve for patients with ALK+ non-small cell lung cancer, attention is shifting toward therapies designed to push disease control even further. Tune in as Dr. Urs Weber examines promising agents in development and discusses the momentum driving the next phase of ALK-targeted treatment.How to Get Young People to Wear Sunscreen
https://reachmd.com/videos/skin-minute/how-to-get-young-people-to-wear-sunscreen/60875/SPOOGE Founder Whitney Hovenic, MD, discusses younger generations' insufficient utilization of sunscreen and the strategies her company has employed in an effort to avoid an increase in melanoma cases in the future.Vitreous Sensing Vitrectomy
https://reachmd.com/clinical-practice/ophthalmology/vitreous-sensing-vitrectomy/54292/Can inflow rate be used to detect whether a vitrectomy probe is actively removing vitreous? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Jordan Deaner, MD, about a novel technique for sensing vitreous during surgery. Dr. Deaner describes a study using porcine eyes